# Optimal Tailored Treatment for H. Pylori Infection

> **NCT04462133** · NA · WITHDRAWN · sponsor: **Incheon St.Mary's Hospital**

## Conditions studied

- Helicobacter Pylori Infection
- Antibiotic Resistant Infection

## Interventions

- **DIAGNOSTIC_TEST:** Dual-priming oligonucleotide-based multiplex polymerase chain reaction (DPO-PCR)

## Key facts

- **NCT ID:** NCT04462133
- **Lead sponsor:** Incheon St.Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study design was changed.
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462133, "Optimal Tailored Treatment for H. Pylori Infection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04462133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*